- Report
- April 2025
- 78 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- January 2024
- 160 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
- Book
- February 2024
- 592 Pages
Buspirone is a medication used to treat mental disorders, such as anxiety and depression. It is a member of the azapirone class of drugs, which act as serotonin receptor agonists. Buspirone is believed to work by increasing the activity of serotonin in the brain, which helps to reduce anxiety and improve mood. It is available in both immediate-release and extended-release formulations.
Buspirone is generally well-tolerated and has fewer side effects than other anti-anxiety medications. It is often used as an alternative to benzodiazepines, which can be habit-forming and have more serious side effects. Buspirone is also used to treat other mental health conditions, such as obsessive-compulsive disorder and post-traumatic stress disorder.
The buspirone market is an important part of the mental disorders drugs market. It is used to treat a variety of mental health conditions, and is generally well-tolerated and has fewer side effects than other medications.
Some companies in the buspirone market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more